The Spectranetics Corp. Company Profile (NASDAQ:SPNC)

About The Spectranetics Corp.

The Spectranetics Corp. logoThe Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Medical and International Medical. Its product offerings in U.S. Medical segment include medical devices used in minimally invasive procedures within the cardiovascular system, including fiber-optic devices and non-fiber-optic products (disposables), an excimer laser system (equipment) and the service of the excimer laser system (service). Its products are used in multiple vascular procedures, including peripheral atherectomy, crossing arterial blockages, coronary atherectomy and thrombectomy. Its International Medical segment is primarily engaged in distribution activities.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: SPNC
  • CUSIP: 84760C10
Key Metrics:
  • Previous Close: $24.95
  • 50 Day Moving Average: $22.97
  • 200 Day Moving Average: $18.08
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -31.19
  • P/E Growth: -1.55
  • Market Cap: $1.07B
  • Outstanding Shares: 42,841,000
  • Beta: 1.27
Additional Links:
Companies Related to The Spectranetics Corp.:

Analyst Ratings

Consensus Ratings for The Spectranetics Corp. (NASDAQ:SPNC) (?)
Ratings Breakdown: 3 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $24.55 (1.62% downside)

Analysts' Ratings History for The Spectranetics Corp. (NASDAQ:SPNC)
DateFirmActionRatingPrice TargetDetails
8/18/2016Piper Jaffray Cos.Boost Price Target$30.00View Rating Details
8/9/2016Needham & Company LLCDowngradeStrong-Buy -> Buy$27.00View Rating Details
8/1/2016RBC Capital MarketsReiterated RatingSector Perform$17.00 -> $24.00View Rating Details
8/1/2016Royal Bank Of CanadaBoost Price TargetSector Perform$17.00 -> $24.00View Rating Details
7/29/2016Canaccord GenuityReiterated RatingBuy$30.00View Rating Details
6/20/2016Stifel NicolausReiterated RatingBuyView Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$23.00View Rating Details
4/26/2016Craig HallumDowngradeBuy -> Hold$17.00View Rating Details
2/25/2016Dougherty & CoReiterated RatingBuy$33.00 -> $25.00View Rating Details
2/12/2016Northcoast ResearchReiterated RatingBuyView Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$28.00 -> $26.00View Rating Details
1/4/2016Benchmark Co.Initiated CoverageBuy$24.00View Rating Details
7/30/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$25.00View Rating Details
12/5/2014JPMorgan Chase & Co.Boost Price TargetOverweight$37.00 -> $40.00View Rating Details
(Data available from 8/28/2014 forward)


Earnings History for The Spectranetics Corp. (NASDAQ:SPNC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.28)($0.26)$65.18 million$67.70 millionViewListenView Earnings Details
4/28/2016Q1($0.29)($0.32)$60.41 million$62.90 millionViewListenView Earnings Details
2/25/2016Q4($0.28)($0.19)$64.21 million$65.20 millionViewListenView Earnings Details
10/22/2015Q315($0.26)($0.17)$60.08 million$61.70 millionViewListenView Earnings Details
7/23/2015Q2($0.31)($0.22)$62.23 million$61.70 millionViewListenView Earnings Details
4/23/2015Q115($0.24)($0.30)$60.20 million$57.40 millionViewN/AView Earnings Details
2/19/2015Q414($0.06)($0.04)$61.70 million$63.00 millionViewListenView Earnings Details
10/23/2014Q314($0.08)($0.05)$57.00 million$58.80 millionViewListenView Earnings Details
7/24/2014Q214($0.09)$0.06$42.60 million$43.60 millionViewListenView Earnings Details
4/23/2014Q114($0.14)($0.14)$39.91 million$39.60 millionViewListenView Earnings Details
2/27/2014Q413$0.02$0.02$41.01 million$41.92 millionViewListenView Earnings Details
10/24/2013Q313$0.01$0.01$38.97 million$39.76 millionViewListenView Earnings Details
7/24/2013Q2 2013($0.02)($0.02)$38.69 million$39.50 millionViewListenView Earnings Details
4/23/2013Q1 2013($0.03)($0.03)$36.59 million$37.67 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.03$0.03$35.47 million$36.75 millionViewListenView Earnings Details
10/30/2012Q312$0.02$0.04$34.43 millionViewN/AView Earnings Details
7/26/2012$0.01$0.02ViewN/AView Earnings Details
2/16/2012$0.02$0.04ViewN/AView Earnings Details
10/26/2011$0.01$0.03ViewN/AView Earnings Details
7/28/2011$0.02ViewN/AView Earnings Details
2/17/2011$0.02$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for The Spectranetics Corp. (NASDAQ:SPNC)
Current Year EPS Consensus Estimate: $-1.11 EPS
Next Year EPS Consensus Estimate: $-0.80 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.31)($0.26)($0.29)
Q2 20162($0.27)($0.25)($0.26)
Q3 20162($0.28)($0.27)($0.28)
Q4 20162($0.26)($0.26)($0.26)
Q1 20171($0.32)($0.32)($0.32)
Q2 20171($0.25)($0.25)($0.25)
Q3 20171($0.23)($0.23)($0.23)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)


Dividend History for The Spectranetics Corp. (NASDAQ:SPNC)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for The Spectranetics Corp. (NASDAQ:SPNC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016Joseph M RuggioDirectorSell5,000$25.00$125,000.00View SEC Filing  
11/6/2015Scott William DrakeCEOBuy38,000$13.24$503,120.00View SEC Filing  
11/5/2015B Kristine JohnsonDirectorBuy2,000$13.00$26,000.00View SEC Filing  
10/28/2015R John FletcherDirectorBuy8,240$12.04$99,209.60View SEC Filing  
10/26/2015R John FletcherDirectorBuy8,000$12.41$99,280.00View SEC Filing  
5/29/2015Austin Bevan ByrdVPBuy2,000$24.46$48,920.00View SEC Filing  
5/22/2015Joseph M RuggioDirectorBuy2,000$24.10$48,200.00View SEC Filing  
5/13/2015Paul GardonVPBuy3,000$24.35$73,050.00View SEC Filing  
5/7/2015Scott William DrakeCEOSell10,000$26.17$261,700.00View SEC Filing  
5/5/2015Daniel A PelakDirectorBuy4,000$24.98$99,920.00View SEC Filing  
5/1/2015Wade A BoweVPSell16,167$25.43$411,126.81View SEC Filing  
4/2/2015Scott William DrakeCEOSell20,000$34.68$693,600.00View SEC Filing  
4/2/2015Wade A BoweVPSell15,000$34.67$520,050.00View SEC Filing  
3/6/2015R John FletcherDirectorSell22,245$34.35$764,115.75View SEC Filing  
2/5/2015Scott William DrakeCEOSell20,000$33.20$664,000.00View SEC Filing  
1/2/2015Robert Michael FuchsVPSell6,000$34.48$206,880.00View SEC Filing  
1/2/2015Scott William DrakeCEOSell20,000$34.10$682,000.00View SEC Filing  
12/11/2014Scott William DrakeCEOSell1,468$33.90$49,765.20View SEC Filing  
11/3/2014Joseph M RuggioDirectorSell5,000$31.80$159,000.00View SEC Filing  
10/2/2014Guy A ChildsCFOSell5,000$26.25$131,250.00View SEC Filing  
9/15/2014Joseph M RuggioDirectorSell10,000$28.19$281,900.00View SEC Filing  
9/4/2014Guy A ChildsCFOSell5,000$28.95$144,750.00View SEC Filing  
9/3/2014Kimberly Mcintosh BridgesSVPSell10,382$29.38$305,023.16View SEC Filing  
8/29/2014Donna Ford-SerbuVPSell3,000$28.26$84,780.00View SEC Filing  
8/7/2014Guy A ChildsCFOSell5,000$26.63$133,150.00View SEC Filing  
7/3/2014Guy A ChildsCFOSell5,000$23.52$117,600.00View SEC Filing  
6/5/2014Guy A ChildsCFOSell5,000$22.00$110,000.00View SEC Filing  
5/1/2014Guy ChildsCFOSell5,000$21.19$105,950.00View SEC Filing  
5/1/2014Wade BoweVPSell10,845$21.18$229,697.10View SEC Filing  
4/3/2014Guy ChildsCFOSell5,000$29.21$146,050.00View SEC Filing  
3/6/2014Guy ChildsCFOSell5,000$30.64$153,200.00View SEC Filing  
2/6/2014Guy ChildsCFOSell5,000$24.90$124,500.00View SEC Filing  
2/3/2014Wade BoweVPSell10,338$25.11$259,587.18View SEC Filing  
1/2/2014Guy ChildsCFOSell5,000$24.90$124,500.00View SEC Filing  
12/5/2013Guy ChildsCFOSell5,000$22.77$113,850.00View SEC Filing  
11/7/2013Guy ChildsCFOSell5,000$20.23$101,150.00View SEC Filing  
11/1/2013Wade A BoweVPSell10,937$20.73$226,724.01View SEC Filing  
10/25/2013Wade A BoweVPSell2,054$19.37$39,785.98View SEC Filing  
8/19/2013Anne Melissa DowlingDirectorSell2,735$17.20$47,042.00View SEC Filing  
8/19/2013Wade BoweVPSell9,632$17.20$165,670.40View SEC Filing  
7/1/2013Jason D HeinVPSell3,000$18.95$56,850.00View SEC Filing  
12/4/2012Jason D HeinVPSell11,200$14.20$159,040.00View SEC Filing  
12/4/2012Joseph M RuggioDirectorSell28,546$14.13$403,354.98View SEC Filing  
11/2/2012R John FletcherDirectorBuy1,000$13.86$13,860.00View SEC Filing  
11/2/2012Scott William DrakeCEOBuy7,000$14.18$99,260.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for The Spectranetics Corp. (NASDAQ:SPNC)
DateHeadline logoAnalysts See The Spectranetics Corporation (NASDAQ:SPNC ... - (NASDAQ:SPNC) - August 21 at 6:37 PM
News IconTechnical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics (NASDAQ:SPNC) - August 18 at 10:35 AM
News IconStocks Trending Alert: Spectranetics Corp(NASDAQ:SPNC), NetApp Inc.(NASDAQ:NTAP) - NYSE Journal (press release) (NASDAQ:SPNC) - August 16 at 10:50 AM logoSpectranetics Shares Up 25.6% Since SmarTrend's Buy Recommendation (SPNC) (NASDAQ:SPNC) - August 15 at 7:54 PM
News IconDirector of The Spectranetics Corporation (NASDAQ:SPNC), Ruggio Joseph M, sells 5,000 shares worth $125,000 (NASDAQ:SPNC) - August 14 at 11:51 AM logoETF’s with exposure to The Spectranetics Corp. : August 11, 2016 (NASDAQ:SPNC) - August 11 at 8:04 PM logoSpectranetics' (SPNC) AngioSculptX Receives CE Mark (NASDAQ:SPNC) - August 11 at 10:51 AM logoSPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:SPNC) - August 11 at 10:51 AM logoFirst Randomized Trial of the Stellarex™ Drug-coated Balloon Presented at the Amputation Prevention Symposium (NASDAQ:SPNC) - August 10 at 8:03 PM logoSpectranetics' (SPNC) AngioSculptX Receives CE Mark - (NASDAQ:SPNC) - August 10 at 10:42 AM logoSpectranetics Receives CE Mark for AngioSculptX™ (NASDAQ:SPNC) - August 10 at 10:42 AM logoSPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:SPNC) - August 10 at 10:42 AM logoThe Spectranetics Corp. :SPNC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:SPNC) - August 9 at 7:51 PM logoThe Spectranetics Corporation (SPNC) Shares are Up 1.73% - Trade Calls (NASDAQ:SPNC) - August 8 at 12:07 PM logoThe Spectranetics Corporation (SPNC) - Financial and Strategic SWOT Analysis Review - New Report Available (NASDAQ:SPNC) - August 7 at 7:06 PM logoThe Spectranetics Corporation (SPNC) is Trading Higher on Unusual Volume for August 03 - (NASDAQ:SPNC) - August 6 at 10:12 AM logoSPECTRANETICS CORP Financials (NASDAQ:SPNC) - August 4 at 7:58 PM logoSpectranetics upgraded by UBS (NASDAQ:SPNC) - August 3 at 7:53 PM logoSpectranetics (NASDAQ:SPNC) target price increased to $24 as disclosed today by RBC Capital Markets (NASDAQ:SPNC) - August 2 at 12:29 PM logoA report released today by Needham about Spectranetics(NASDAQ:SPNC) bumps the target price to $27 (NASDAQ:SPNC) - August 1 at 12:09 PM logoThe Spectranetics Corporation (SPNC) Jumps 7.96% on July 29 - (NASDAQ:SPNC) - July 30 at 6:46 PM logoSPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:SPNC) - July 29 at 6:44 AM logoEdited Transcript of SPNC earnings conference call or presentation 28-Jul-16 8:30pm GMT (NASDAQ:SPNC) - July 29 at 1:05 AM logoSpectranetics reports 2Q loss (NASDAQ:SPNC) - July 28 at 5:45 PM logoThe Spectranetics Corporation (SPNC) Hits New 52-week High During July 25 Session - (NASDAQ:SPNC) - July 28 at 10:48 AM logoQ2 2016 Spectranetics Corp Earnings Release - After Market Close (NASDAQ:SPNC) - July 28 at 7:07 AM logoSpectranetics : QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment (NASDAQ:SPNC) - July 25 at 11:56 AM logoQT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment (NASDAQ:SPNC) - July 25 at 8:19 AM
News IconThe Spectranetics Corporation (NASDAQ:SPNC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SPNC) - July 23 at 11:21 AM logoBroker Outlook For The Spectranetics Corporation (NASDAQ:SPNC) - Fiscal Standard (NASDAQ:SPNC) - July 23 at 11:21 AM logoFederal Circuit Court Rules in Appeal (NASDAQ:SPNC) - July 21 at 7:52 PM logoSpectranetics (SPNC) Says Federal Circuit Court Reversed in Part and Affirmed in Part Court Rulings (NASDAQ:SPNC) - July 21 at 7:52 PM
News IconSpectranetics Corporation (NASDAQ:SPNC) Shorted Shares ... - Press Telegraph (NASDAQ:SPNC) - July 20 at 8:30 PM logoThe Spectranetics Corporation (SPNC) Jumps 5.19% on July 20 - (NASDAQ:SPNC) - July 20 at 8:30 PM logo12-month Results of the ILLUMENATE European Randomized Clinical Trial to be Presented at the Amputation Prevention Symposium (NASDAQ:SPNC) - July 20 at 9:00 AM
News IconStock in Positive Territory for the Quarter: The Spectranetics Corporation (NASDAQ:SPNC) - Engelwood Daily (NASDAQ:SPNC) - July 19 at 8:31 AM logoWhat's The Growth Forecast For The Spectranetics Corporation (NASDAQ:SPNC)? - (NASDAQ:SPNC) - July 19 at 8:31 AM
News IconWere Analysts Bearish Spectranetics Corp (NASDAQ:SPNC) This Week? - Press Telegraph (NASDAQ:SPNC) - July 19 at 8:31 AM
News IconShare Performance Summary for: The Spectranetics Corporation (NASDAQ:SPNC) - Press Telegraph (NASDAQ:SPNC) - July 18 at 12:02 PM logoThe Spectranetics Corporation Realized Volatility Hits Elevated Level - CML News (NASDAQ:SPNC) - July 13 at 10:26 AM logoThe Spectranetics Corporation (NASDAQ:SPNC)'s Growth Projection - (NASDAQ:SPNC) - July 11 at 7:27 PM
News IconStock on the Rise for the Quarter: The Spectranetics Corporation (NASDAQ:SPNC) - Engelwood Daily (NASDAQ:SPNC) - July 11 at 11:44 AM
News IconStock Rating Watch and Earnings Insight for The Spectranetics Corporation (NASDAQ:SPNC) - Press Telegraph (NASDAQ:SPNC) - July 11 at 11:44 AM
News IconStock Performance Rundown on: The Spectranetics Corporation (NASDAQ:SPNC) - Press Telegraph (NASDAQ:SPNC) - July 11 at 11:44 AM
News IconCompany Stock Focus for The Spectranetics Corporation (NASDAQ:SPNC): Which Way Will Shares Head? - Press Telegraph (NASDAQ:SPNC) - July 8 at 7:29 PM
News IconPura Vida Investments LLC Increased Spectranetics Corp (NASDAQ:SPNC) by $3.51 Million as Shares Declined - Press Telegraph (NASDAQ:SPNC) - July 8 at 7:29 PM logoThe Spectranetics Corporation (SPNC) : Analyst Rating Update - Trade Calls (NASDAQ:SPNC) - July 7 at 7:37 PM logoSpectranetics to Host Second Quarter 2016 Conference Call on July 28, 2016 (NASDAQ:SPNC) - July 7 at 9:00 AM logoThe Spectranetics Corporation (NASDAQ:SPNC) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:SPNC) - July 5 at 11:55 AM
News IconSpectranetics Corp (NASDAQ:SPNC) Q1 2016 Sentiment - Press Telegraph (NASDAQ:SPNC) - July 5 at 11:55 AM


The Spectranetics Corp. (NASDAQ:SPNC) Chart for Sunday, August, 28, 2016

Last Updated on 8/28/2016 by Staff